(MENAFNEditorial) FIT Biotech Oy: FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board FIT Biotech Oy
Company release 23.8.2017 at 9.30 EET
FIT Biotech Board elected Erkki Pekkarinen to the Deputy Chairman of the Board
FIT Biotech Oys' Board of Directors elected in its meeting 22.8.2017 Board member Erkki Pekkarinen to the deputy Chairman of the Board.
FIT BIOTECH OY
Further information: Rabbe Slätis Chairman of the Board FIT Biotech Oy Tel: +358 40 8406749 E-mail:
Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000
About FIT Biotech
FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.
FIT Biotech applies GTU® technology in its drug development programs. FIT Biotech applies GTU® technology in its drug development programs. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.
FIT Biotech K-shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.
DISTRIBUTION:Nasdaq HelsinkiCentral media
MENAFN2308201700703653ID1095762760
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.